{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:06:35Z","timestamp":1748664395666,"version":"3.41.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Unregulated herbal supplements can pose significant health risks due to undisclosed ingredients. Tawon Liar, an Indonesian product marketed as an \"all-natural\" remedy, claims to alleviate pain and boost immunity but lacks stringent regulatory oversight. We report a unique case of Tawon Liar-induced Immunoglobulin A (IgA) vasculitis and exacerbation of psoriasis, highlighting the potential dangers associated with misadvertised supplements.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 53-year-old migrant worker from Mexico with a history of psoriasis and ankylosing spondylitis, effectively managed with adalimumab, presented with new-onset rashes on his extremities. Physical examination revealed palpable purpura on the lower legs and erythematous papules and plaques with pustules on the upper extremities. Dermoscopic analysis suggested IgA vasculitis and pustular psoriasis. The patient denied recent infections, new medications, or over-the-counter drug use. However, after thorough questioning, it was revealed that he had been intermittently ingesting Tawon Liar for chronic musculoskeletal pain. The supplement, obtained from a coworker, contained undisclosed ingredients including meloxicam, ketorolac, and dexamethasone. Laboratory tests ruled out renal involvement, and biopsies were not performed due to financial constraints. The patient was advised to discontinue Tawon Liar and was treated with topical corticosteroids, leading to substantial improvement and resolution of symptoms within one week.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This case underscores the potential dangers of herbal supplements containing hidden pharmacologic agents. It highlights the need for clinicians to diligently inquire about supplement use during patient evaluations, especially for vulnerable populations facing language barriers and limited access to healthcare. Public health authorities should enhance efforts to disseminate drug safety information across diverse languages and platforms to mitigate health risks associated with such products.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13256-025-05167-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:00:24Z","timestamp":1748595624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunoglobulin A vasculitis and pustular psoriasis precipitated by Tawon Liar: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Mengyi","family":"Zha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4658-4553","authenticated-orcid":false,"given":"Delaney D.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"5167_CR1","unstructured":"Research C for DE and. Public Notification: Tawon Liar contains hidden drug ingredient. FDA [Internet]. 2023. https:\/\/www.fda.gov\/drugs\/medication-health-fraud\/public-notification-tawon-liar-contains-hidden-drug-ingredient. Accessed 17 Jul 2024."},{"key":"5167_CR2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/amajethics.2022.361","volume":"24","author":"V Clinard","year":"2022","unstructured":"Clinard V, Smith JD. How should clinicians respond to patient interest in dietary supplements to treat serious chronic illness? AMA J Ethics. 2022;24:361\u20137.","journal-title":"AMA J Ethics"},{"key":"5167_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s10903-012-9661-z","volume":"15","author":"P Gardiner","year":"2013","unstructured":"Gardiner P, Whelan J, White LF, Filippelli AC, Bharmal N, Kaptchuk TJ. A systematic review of the prevalence of herb usage among racial\/ethnic minorities in the United States. J Immigr Minor Health. 2013;15:817\u201328.","journal-title":"J Immigr Minor Health"},{"key":"5167_CR4","unstructured":"TawonLiar.com. Tawon Liar Avispa Salvaje Capsules 100% Herbs For Cholesterol, Stamina, Gout [Internet]. Tawonliar. 2025. https:\/\/www.tawonliar.com\/product-30. Accessed 12 Feb 2025."},{"key":"5167_CR5","doi-asserted-by":"crossref","unstructured":"Gomathy S. Henoch\u2013Sch\u00f6nlein purpura in children and adults. J Am Acad Dermatol. 2012;66:AB130.","DOI":"10.1016\/j.jaad.2011.11.549"},{"key":"5167_CR6","unstructured":"Reamy BV, Servey JT, Williams PM. Henoch-Sch\u00f6nlein Purpura (IgA Vasculitis): Rapid Evidence Review. https:\/\/www.aafp.org\/pubs\/afp\/issues\/2020\/0815\/p229.html. Accessed 17 Jul 2024."},{"key":"5167_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102707","volume":"20","author":"C Rasmussen","year":"2021","unstructured":"Rasmussen C, Tisseyre M, Garon-Czmil J, Atzenhoffer M, Guillevin L, Salem J-E, et al. Drug-induced IgA vasculitis in children and adults: revisiting drug causality using a dual pharmacovigilance-based approach. Autoimmun Rev. 2021;20: 102707.","journal-title":"Autoimmun Rev"},{"key":"5167_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.molimm.2022.11.015","volume":"153","author":"X Liu","year":"2023","unstructured":"Liu X, Wang J, Shen L, Wang R, Zhang L, Li C. Single-cell atlas reveals a high selection of IgA1- or IgG1-expressing plasma cells in patients with psoriasis. Mol Immunol. 2023;153:85\u201393.","journal-title":"Mol Immunol"},{"key":"5167_CR9","first-page":"382","volume":"19","author":"J Zadrazil","year":"2006","unstructured":"Zadrazil J, Tich\u00fd T, Hor\u00e1k P, Nikorjakov\u00e1 I, Z\u00edma P, Krejc\u00ed K, et al. IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of \u201cpsoriatic nephropathy.\u201d J Nephrol. 2006;19:382\u20136.","journal-title":"J Nephrol"},{"key":"5167_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00403-024-03465-4","volume":"316","author":"Y Chen","year":"2024","unstructured":"Chen Y, Huang M, You Z, Sa R, Zhao L, Ku C, et al. Unveiling the genetic link and pathogenesis between psoriasis and IgA nephropathy based on Mendelian randomization and transcriptome data analyses. Arch Dermatol Res. 2024;316:717.","journal-title":"Arch Dermatol Res"},{"key":"5167_CR11","unstructured":"Mahmoodi AN, Patel P, Kim PY. Ketorolac. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545172\/. Accessed 3 Aug 2024."},{"issue":"Suppl 1","key":"5167_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/rheumatology\/35.suppl_1.13","volume":"35","author":"D T\u00fcrck","year":"1996","unstructured":"T\u00fcrck D, Roth W, Busch U. A review of the clinical pharmacokinetics of meloxicam. Br J Rheumatol. 1996;35(Suppl 1):13\u20136.","journal-title":"Br J Rheumatol"},{"key":"5167_CR13","doi-asserted-by":"crossref","unstructured":"Cronin J, Kennedy U, McCoy S, An Fhail\u00ed SN, Crispino-O\u2019Connell G, Hayden J, et al. Single dose oral dexamethasone versus multi-dose prednisolone in the treatment of acute exacerbations of asthma in children who attend the emergency department: study protocol for a randomized controlled trial. Trials. 2012;13:141.","DOI":"10.1186\/1745-6215-13-141"},{"key":"5167_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00403-025-03925-5","volume":"317","author":"H Zheng","year":"2025","unstructured":"Zheng H, Liu L, Yang M, Wang S. Antibiotic-induced IgA vasculitis: insights from a real-world retrospective analysis and pharmacovigilance assessment. Arch Dermatol Res. 2025;317:383.","journal-title":"Arch Dermatol Res"},{"key":"5167_CR15","unstructured":"Yousif M, Vigil NH, Haddad R. Drug-induced IgA vasculitis in an adult. Cureus. 15:e34270."},{"key":"5167_CR16","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1038\/s41598-020-63146-w","volume":"10","author":"B Garc\u00eda-Garc\u00eda","year":"2020","unstructured":"Garc\u00eda-Garc\u00eda B, Aub\u00e1n-Pariente J, Mungu\u00eda-Calzada P, Vivanco B, Argenziano G, V\u00e1zquez-L\u00f3pez F. Development of a clinical-dermoscopic model for the diagnosis of urticarial vasculitis. Sci Rep. 2020;10:6092.","journal-title":"Sci Rep"},{"key":"5167_CR17","unstructured":"Lallas A, Toffoli L. Dermoscopy in general dermatology \/ Inflammoscopy - dermoscopedia [Internet]. Dermoscopedia.org. 2022. https:\/\/dermoscopedia.org\/Inflammoscopy. Accessed 12 Feb 2025."},{"key":"5167_CR18","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1401a51","volume":"14","author":"OSK Bakay","year":"2024","unstructured":"Bakay OSK, Kacar N, Gonulal M, Demirkan NC, Cenk H, Goksin S, et al. Dermoscopic features of cutaneous vasculitis. Dermatol Pract Concept. 2024;14: e2024051.","journal-title":"Dermatol Pract Concept"},{"key":"5167_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/CDR.CDR_19_19","volume":"4","author":"BS Ankad","year":"2020","unstructured":"Ankad BS, Reshme AS, Nikam BP, Drago ND. Dermoscopic differentiation of pustular psoriasis and tinea incognito. Clin Dermatol Rev. 2020;4:136.","journal-title":"Clin Dermatol Rev"},{"key":"5167_CR20","unstructured":"Shah M, Al Aboud DM, Crane JS, Kumar S. Pustular Psoriasis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537002\/. Accessed 17 Jul 2024."},{"key":"5167_CR21","doi-asserted-by":"publisher","first-page":"5954","DOI":"10.1073\/pnas.0812782106","volume":"106","author":"HP Lemos","year":"2009","unstructured":"Lemos HP, Grespan R, Vieira SM, Cunha TM, Verri WA, Fernandes KSS, et al. Prostaglandin mediates IL-23\/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc Natl Acad Sci U S A. 2009;106:5954\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5167_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaad.2020.09.024","volume":"87","author":"MA Hadavand","year":"2022","unstructured":"Hadavand MA, Kaffenberger B, Cartron AM, Trinidad JCL. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis. J Am Acad Dermatol. 2022;87:632\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 1","key":"5167_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1365-4632.2008.03954.x","volume":"47","author":"M Kucharekova","year":"2008","unstructured":"Kucharekova M, Winnepenninckx V, Frank J, Poblete-Guti\u00e9rrez P. Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis\u2014a therapeutic challenge. Int J Dermatol. 2008;47(Suppl 1):25\u20138.","journal-title":"Int J Dermatol"},{"key":"5167_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3337","volume":"1","author":"J Tucker","year":"2018","unstructured":"Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M. Unapproved pharmaceutical ingredients included in dietary supplements associated with US food and drug administration warnings. JAMA Netw Open. 2018;1: e183337.","journal-title":"JAMA Netw Open"},{"key":"5167_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1089\/acm.2008.0290","volume":"14","author":"DH Mehta","year":"2008","unstructured":"Mehta DH, Gardiner PM, Phillips RS, McCarthy EP. Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions. J Altern Complement Med. 2008;14:1263\u20139.","journal-title":"J Altern Complement Med"},{"key":"5167_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.22743","volume":"6","author":"H Joo","year":"2023","unstructured":"Joo H, Fern\u00e1ndez A, Wick EC, Moreno Lepe G, Manuel SP. Association of language barriers with perioperative and surgical outcomes: a systematic review. JAMA Netw Open. 2023;6: e2322743.","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05167-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05167-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05167-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T09:00:27Z","timestamp":1748595627000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05167-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5167"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05167-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report represents a single anonymized case description that does not include any identifiable patient information; IRB review was deemed unnecessary. The authors obtained written informed consent from the patient for their photographs and medical information to be published in print and online and with the understanding that this information may be publicly available.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"259"}}